A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
Top Cited Papers
- 20 November 2001
- journal article
- Published by Elsevier BV in Journal of Immunological Methods
- Vol. 260 (1-2), 157-172
- https://doi.org/10.1016/s0022-1759(01)00535-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- AIDS Vaccines Show Promise After Years of FrustrationScience, 2001
- Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining AssaysJournal of Virology, 2001
- Efficacy Testing of Recombinant Human Immunodeficiency Virus (HIV) gp160 as a Therapeutic Vaccine in Early‐Stage HIV‐1–Infected VolunteersThe Journal of Infectious Diseases, 2000
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in thaisHuman Immunology, 1997
- HIV Type 1 Vaccine-Induced Cytotoxic T Cell Responses in Phase I Clinical Trials: Detection, Characterization, and QuantitationAIDS Research and Human Retroviruses, 1997
- HLA Class I nucleotide sequences, 1995Tissue Antigens, 1995
- Conservation of T cell receptor usage by HLA B27‐restricted influenza‐specific cytotoxic T lymphocytes suggests a general pattern for antigen‐specific major histocompatibility complex class I‐restricted responsesEuropean Journal of Immunology, 1993
- HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + PopulationScience, 1993
- CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1Proceedings Of The Royal Society B-Biological Sciences, 1991